Quidel | QDEL - Sales Revenues


Quidel reported $724M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Agilent USD 1.8B 63M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Danaher USD 6.84B 790M Dec/2025
Exact Sciences USD 878.38M 27.38M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Illumina USD 1.16B 80M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Myriad Genetics USD 209.8M 4.1M Dec/2025
Neogen USD 224.69M 15.5M Sep/2025
OraSure Technologies USD 39.92M 14.42M Sep/2024
Pacific Biosciences Of California USD 39.97M 3.95M Sep/2024
Quidel USD 724M 24M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
STAAR Surgical USD 94.7M 50.4M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Waters USD 932M 132M Dec/2025